Shionogi
Anindita (Ani) Sinha is a seasoned pharmaceutical executive with extensive experience in commercial operations, market access, and business strategy. Currently serving as Vice President of Commercial Operations at Shionogi Inc., Anindita has previously held key leadership roles such as Vice President and Chief of Staff to the CEO at Intercept Pharmaceuticals, and Vice President of Business Insights, Strategy, and Analytics at Optinose. Anindita's career includes significant positions at Boehringer Ingelheim and Pfizer, focusing on market access and operations. Educational credentials include a PhD ABD and an MPhil in Microbiology from Yale University.
This person is not in any teams
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.